Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Hovione
23 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Strategic Partnership
Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications
PR-M03-23-06
CDMO Leadership Award
Hovione Receives the 2023 CDMO Leadership Award in All Six Categories and Is Champion in Compatibility and Expertise
PR-M03-23-01
Continuous Tableting
Hovione and GEA Announce a Strategic Collaboration to Advance Continuous Tableting
PR-M12-22-02
Global License Agreement
Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program
PR-M05-22-04
Business Leadership
Jean-Luc Herbeaux to Become Hovione CEO
PR-M02-22-23
Strategic Partnership
Hovione and Zerion Pharma Announce a Strategic Partnership to Market the Dispersome® Technology Platform
PR-M02-22-19
Strategic Collaboration
Hovione and iBET Announce Strategic Collaboration
PR-M05-21-020
Ophthalmology
Hovione Completes its Phase II Clinical Trial of the First Minocycline Ophthalmic Showing Promise in Dry Eye Disease Associated with Inflamed Meibomian Gland Dysfunction
PR-M03-21-003
Screening Service
Hovione Launches ASD-HIPROS the Most Advanced Screening Service for Optimal Spray Dried Dispersions Formulation
PR-M11-20-033
COVID-19
Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury for COVID-19
PR-M09-20-26
Drug Development
Bilim Pharmaceuticals, H&T Presspart and Hovione Technology Unveil Collaboration for New Asthma Product: Ventofor Combi Fix Delivered by PowdAir Plus
PR-M09-20-NI-02
Leadership
Hovione Announces the Appointment of Jean-Luc Herbeaux as Chief Operating Officer
PR-M05-20-NI-006
Phase II
Hovione Announces Successful End-of-Phase 2 Meeting with the FDA and Outlines Phase 3 Program for Minocycline Topical Gel
PR-M09-19-NI-047
Collaboration
Hovione Technology Signs Collaboration Agreement with Kiel University
PR-M09-19-NI-012
Formulation
Developing and Characterizing DPI Formulations for Biologics
PAP-Q1-2019-CL-002
Finance
Hovione Issues $50 Million Bond
PR-M01-19-NI-081
Formulation
The Coming of Age of Amorphous Solid Dispersions
PAP-Q4-18-CL-004
Expanded Capacity
Hovione Reports on Recent Capacity Expansion and Future Plans to Support Growth
PR-M03-18-NI-081
Regulatory
Compliance at Hovione, Annual Inspection Review
PR-M03-18-NI-037
Inhalation
Hovione strengthens Inhalation Services portfolio
PR-M01-18-NI-084
Clinical Trial
Hovione Announces Enrollment of First Patient in MARS a Phase 2 Clinical Trial
PR-M12-17-NI-005
Quality by Design
Speeding Development and Reducing Costs with Analytical Quality by Design
PAP-Q2-17-CL-006
Innovation is Key
PTV-M11-16-AP-003
.svg)
